4,249 XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Steven Duncan Wood | Director | Grant, award, or other acquisition of securities at price $ 3.17 per share. | 17 May 2024 | 3,100 | 4,359 (0%) | 0% | 3.2 | 9,827 | Common Stock |
| James Flynn | Director | Grant, award, or other acquisition of securities at price $ 3.16 per share. | 16 May 2024 | 7,900 | 7,900 (0%) | 0% | 3.2 | 24,981 | Common Stock |
| James Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 6,700 | 6,700 | - | - | Stock Options (Right to Buy) | |
| Flynn James | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Wood Steven Duncan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Steven Duncan Wood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 6,700 | 6,700 | - | - | Stock Option (Right to Buy) | |
| James Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 6,700 | 6,700 | - | - | Stock Option (Right to Buy) | |
| Duncan Steven Wood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 6,700 | 6,700 | - | - | Stock Option (Right to Buy) | |
| Wood Steven Duncan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| James Flynn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| David M. Urso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 166,571 | 166,571 | - | - | Stock Option (Right to Buy) | |
| Charles V. Baltic | Director | Purchase of securities on an exchange or from another person at price $ 0.23 per share. | 28 Feb 2023 | 81,500 | 105,750 (0%) | 0% | 0.2 | 18,338 | Common Stock |
| Daniel P. Gold | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 1,496,000 | 1,496,000 | - | - | Stock Option (Right to Buy) | |
| Frederick W. Driscoll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 87 | 87,500 | - | - | Stock Option (Right to Buy) | |
| Thomas C. Reynolds | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 87,500 | 87,500 | - | - | Stock Option (Right to Buy) | |
| Sujay R. Kango | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 87,500 | 87,500 | - | - | Stock Option (Right to Buy) | |
| Christine A. White | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 87,500 | 87,500 | - | - | Stock Option (Right to Buy) | |
| Tamar D. Howson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 87,500 | 87,500 | - | - | Stock Option (Right to Buy) | |
| Richard G. Ghalie | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.54 per share. | 05 Jul 2022 | 8,196 | 28,927 (0%) | 0% | 0.5 | 4,426 | Common Stock |
| Richard G. Ghalie | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 560,000 | 560,000 | - | - | Stock Option (Right to Buy) | |
| Brian G. Drazba | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 350,000 | 350,000 | - | - | Stock Option (Right to Buy) | |
| Cheryl L. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 87,500 | 87,500 | - | - | Stock Option (Right to Buy) | |
| Charles V. Baltic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 87,500 | 87,500 | - | - | Stock Option (Right to Buy) | |
| Nicholas R. Glover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 87,500 | 87,500 | - | - | Stock Option (Right to Buy) | |
| David M. Urso | Chief Operating Officer & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 1,050,000 | 1,050,000 | - | - | Stock Option (Right to Buy) | |
| Sujay Kango | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2021 | 58,334 | 58,334 | - | - | Stock Option (Right to Buy) | |
| Daniel P. Gold | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.94 per share. | 01 Jul 2021 | 41,320 | 417,312 (0%) | 0% | 2.9 | 121,481 | Common Stock |
| Daniel P. Gold | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 855,000 | 855,000 | - | - | Stock Option (Right to Buy) | |
| Frederick W. Driscoll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Thomas C. Reynolds | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Christine A. White | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Kevan E. Clemens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Tamar D. Howson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Richard G. Ghalie | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 320,000 | 320,000 | - | - | Stock Option (Right to Buy) | |
| Brian G. Drazba | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Cheryl L. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Charles V. Baltic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Nicholas R. Glover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| David M. Urso | Chief Operating Officer & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 600,000 | 600,000 | - | - | Stock Option (Right to Buy) | |
| David M. Urso | Chief Operating Officer & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.94 per share. | 01 Jul 2021 | 24,825 | 49,281 (0%) | 0% | 2.9 | 72,986 | Common Stock |
| Daniel P. Gold | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.52 per share. | 25 May 2021 | 5,000 | 458,632 (0%) | 0% | 2.5 | 12,600 | Common Stock |
| Daniel P. Gold | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2021 | 5,000 | 675,000 | - | - | Stock Option (Right to Buy) | |
| Richard G. Ghalie | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Frederick W. Driscoll | Director | Sale of securities on an exchange or to another person at price $ 4.02 per share. | 23 Feb 2021 | 25,000 | 37,500 (0%) | 0% | 4.0 | 100,625 | Common Stock |
| Daniel P. Gold | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2020 | 12,000 | 275,500 | - | - | Stock Option (Right to Buy) | |
| Daniel P. Gold | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.57 per share. | 23 Jul 2020 | 12,000 | 453,632 (0%) | 0% | 1.6 | 18,840 | Common Stock |
| Daniel P. Gold | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 680,000 | 680,000 | - | - | Stock Option (Right to Buy) | |
| Daniel P. Gold | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 80,000 | 441,632 (0%) | 0% | 0 | Common Stock | |
| Frederick W. Driscoll | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Thomas C. Reynolds | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Christine A. White | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Kevan E. Clemens | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Tamar D. Howson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Brian G. Drazba | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 230,000 | 230,000 | - | - | Stock Option (Right to Buy) | |
| Robert D. Mass | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 230,000 | 230,000 | - | - | Stock Option (Right to Buy) | |
| Cheryl L. Cohen | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Charles V. Baltic | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Nicholas R. Glover | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| David M. Urso | Chief Operating Officer & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 50,000 | 74,106 (0%) | 0% | 0 | Common Stock | |
| David M. Urso | Chief Operating Officer & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 525,000 | 525,000 | - | - | Stock Option (Right to Buy) | |
| Cheryl L. Cohen | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2020 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Daniel P. Gold | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 19 Dec 2019 | 18,750 | 361,632 (0%) | 0% | 1.6 | 30,000 | Common Stock |
| Frederick W. Driscoll | None | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 19 Dec 2019 | 62,500 | 62,500 (0%) | 0% | 1.6 | 100,000 | Common Stock |
| Thomas C. Reynolds | None | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 19 Dec 2019 | 10,000 | 10,000 (0%) | 0% | 1.6 | 16,000 | Common Stock |
| Brian G. Drazba | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 19 Dec 2019 | 12,500 | 37,500 (0%) | 0% | 1.6 | 20,000 | Common Stock |
| Daniel P. Gold | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Sep 2019 | 20,000 | 287,500 | - | - | Stock Option (Right to Buy) | |
| Daniel P. Gold | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.57 per share. | 27 Sep 2019 | 20,000 | 342,882 (0%) | 0% | 1.6 | 31,400 | Common Stock |
| Christine A. White | None | Purchase of securities on an exchange or from another person at price $ 1.74 per share. | 06 Sep 2019 | 15,000 | 15,000 (0%) | 0% | 1.7 | 26,075 | Common Stock |
| Daniel P. Gold | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2019 | 680,000 | 680,000 | - | - | Stock Option (Right to Buy) | |
| Frederick W. Driscoll | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2019 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Thomas C. Reynolds | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2019 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| William D. Rueckert | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2019 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Christine A. White | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2019 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Kevan E. Clemens | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2019 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Tamar D. Howson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2019 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Brian G. Drazba | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2019 | 230,000 | 230,000 | - | - | Stock Option (Right to Buy) | |
| Robert D. Mass | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2019 | 230,000 | 230,000 | - | - | Stock Option (Right to Buy) | |
| Charles V. Baltic | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2019 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Nicholas R. Glover | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2019 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| David M. Urso | Chief Operating Officer & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2019 | 350,000 | 350,000 | - | - | Stock Option (Right to Buy) | |
| Daniel P. Gold | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.75 per share. | 06 Aug 2018 | 50,938 | 322,882 (0%) | 0% | 3.8 | 191,018 | Common Stock |
| Robert D. Mass | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.75 per share. | 06 Aug 2018 | 17,709 | 33,661 (0%) | 0% | 3.8 | 66,409 | Common Stock |
| David M. Urso | Chief Operating Officer & GC | Sale of securities on an exchange or to another person at price $ 3.58 per share. | 06 Aug 2018 | 9,500 | 24,106 (0%) | 0% | 3.6 | 34,044 | Common Stock |
| David M. Urso | Chief Operating Officer & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.75 per share. | 06 Aug 2018 | 17,764 | 33,606 (0%) | 0% | 3.8 | 66,615 | Common Stock |
| Daniel P. Gold | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2018 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Frederick W. Driscoll | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2018 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Thomas C. Reynolds | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2018 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| William D. Rueckert | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2018 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Christine A. White | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2018 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Kevan E. Clemens | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2018 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Brian G. Drazba | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2018 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Robert D. Mass | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2018 | 130,000 | 130,000 | - | - | Stock Option (Right to Buy) | |
| Charles V. Baltic | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2018 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Nicholas R. Glover | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2018 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| David M. Urso | Chief Operating Officer & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2018 | 220,000 | 220,000 | - | - | Stock Option (Right to Buy) | |
| Daniel P. Gold | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2018 | 380,000 | 380,000 | - | - | Stock Option (Right to Buy) | |
| Brian G. Drazba | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2018 | 130,000 | 130,000 | - | - | Stock Option (Right to Buy) | |
| Robert D. Mass | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2018 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| David M. Urso | Sr. V.P. and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2018 | 130,000 | 130,000 | - | - | Stock Option (Right to Buy) | |
| Daniel P. Gold | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.07 per share. | 29 Mar 2018 | 128,920 | 271,080 (0%) | 0% | 2.1 | 266,864 | Common Stock |
| Frederick W. Driscoll | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2018 | 33,333 | 33,333 | - | - | Options to purchase shares of common stock | |
| Charles V. Baltic | None | Sale of securities on an exchange or to another person at price $ 2.21 per share. | 27 Nov 2017 | 11,000 | 13,250 (0%) | 0% | 2.2 | 24,272 | Common Stock, par value $0.00000002 |
| Charles V. Baltic | None | Purchase of securities on an exchange or from another person at price $ 2.25 per share. | 27 Nov 2017 | 11,000 | 24,250 (0%) | 0% | 2.3 | 24,801 | Common Stock, par value $0.00000002 |
| Daniel P. Gold | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2017 | 380,000 | 1,234,166 | - | - | Option to purchase shares of common stock | |
| Thomas C. Reynolds | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2017 | 40,000 | 121,049 | - | - | Option to purchase shares of common stock | |
| William D. Rueckert | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2017 | 40,000 | 122,730 | - | - | Option to purchase shares of common stock | |
| Christine A. White | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2017 | 40,000 | 122,730 | - | - | Option to purchase shares of common stock | |
| Kevan E. Clemens | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2017 | 40,000 | 112,667 | - | - | Option to purchase shares of common stock | |
| Brian G. Drazba | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2017 | 50,000 | 200,000 | - | - | Option to purchase shares of common stock | |
| Robert D. Mass | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2017 | 135,000 | 555,556 | - | - | Option to purchase shares of common stock | |
| Charles V. Baltic | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2017 | 40,000 | 122,730 | - | - | Option to purchase shares of common stock | |
| Nicholas R. Glover | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2017 | 40,000 | 118,793 | - | - | Option to purchase shares of common stock | |
| David M. Urso | Sr. V.P. and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2017 | 130,000 | 537,500 | - | - | Option to purchase shares of common stock | |
| Brian G. Drazba | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2017 | 150,000 | 150,000 | - | - | Option to purchase shares of common stock | |
| Daniel P. Gold | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2016 | 102,740 | 102,740 | - | - | Restricted stock units | |
| Thomas Zech | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2016 | 17,123 | 17,123 | - | - | Restricted stock units | |
| Robert Mass | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2016 | 51,370 | 51,370 | - | - | Restricted stock units | |
| David M. Urso | Sr. V.P. and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2016 | 51,370 | 51,370 | - | - | Restricted stock units | |
| Kevan E. Clemens | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2016 | 40,000 | 72,667 | - | - | Option to purchase shares of common stock | |
| Daniel P. Gold | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2016 | 380,000 | 870,832 | - | - | Option to purchase shares of common stock | |
| Christine A. White | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2016 | 40,000 | 86,924 | - | - | Option to purchase shares of common stock | |
| William D. Rueckert | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2016 | 40,000 | 86,924 | - | - | Option to purchase shares of common stock | |
| Thomas C. Reynolds | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2016 | 40,000 | 81,049 | - | - | Option to purchase shares of common stock | |
| Leah Cann | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2016 | 40,000 | 86,924 | - | - | Option to purchase shares of common stock | |
| Thomas Zech | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2016 | 110,000 | 338,757 | - | - | Option to purchase shares of common stock | |
| Robert Mass | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2016 | 135,000 | 420,556 | - | - | Option to purchase shares of common stock | |
| Charles V. Baltic | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2016 | 40,000 | 86,924 | - | - | Option to purchase shares of common stock | |
| Nicholas R. Glover | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2016 | 40,000 | 78,793 | - | - | Option to purchase shares of common stock | |
| David M. Urso | Sr. V.P. and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2016 | 130,000 | 407,500 | - | - | Option to purchase shares of common stock | |
| Kevan Clemens | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2015 | 20,000 | 32,667 | - | - | Option to purchase shares of common stock | |
| Daniel P. Gold | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2015 | 307,500 | 490,832 | - | - | Option to purchase shares of common stock | |
| Christine A. White | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2015 | 20,000 | 46,924 | - | - | Option to purchase shares of common stock | |
| William D. Rueckert | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2015 | 20,000 | 46,924 | - | - | Option to purchase shares of common stock | |
| Thomas C. Reynolds | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2015 | 20,000 | 41,049 | - | - | Option to purchase shares of common stock | |
| Leah Cann | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2015 | 20,000 | 46,924 | - | - | Option to purchase shares of common stock | |
| Thomas Zech | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2015 | 90,000 | 228,757 | - | - | Option to purchase shares of common stock | |
| Robert Mass | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2015 | 112,500 | 315,159 | - | - | Option to purchase shares of common stock | |
| Charles V. Baltic | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2015 | 20,000 | 46,924 | - | - | Option to purchase shares of common stock | |
| Nicholas Glover | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2015 | 20,000 | 38,793 | - | - | Option to purchase shares of common stock | |
| David M. Urso | Sr. V.P. and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2015 | 127,500 | 277,500 | - | - | Option to purchase shares of common stock | |
| Philippe O. Chambon | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 24 Mar 2015 | 1,601,390 | 0 | - | - | Common Stock | |
| Charles V. Baltic | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 21 Jan 2015 | 5,000 | 24,250 | - | - | Common Stock, par value $0.00000002 | |
| Charles V. Baltic | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Dec 2014 | 1,500 | 19,250 | - | - | Common Stock, par value $0.00000002 | |
| Charles V. Baltic | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Dec 2014 | 1,500 | 5,350 | - | - | Common Stock, par value $0.00000002 | |
| Philippe O. Chambon | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 08 Dec 2014 | 9,004 | 1,671,471 | - | - | Common Stock | |
| Philippe O. Chambon | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 08 Dec 2014 | 70,081 | 1,601,390 | - | - | Common Stock | |
| Kevan Clemens | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2014 | 12,667 | 12,667 | - | - | Option to purchase shares of common stock | |
| Daniel P. Gold | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2014 | 100,000 | 220,062 | - | - | Option to purchase shares of common stock | |
| Christine A. White | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2014 | 8,000 | 26,924 | - | - | Option to purchase shares of common stock | |
| William D. Rueckert | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2014 | 8,000 | 26,924 | - | - | Option to purchase shares of common stock | |
| Thomas C. Reynolds | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2014 | 8,000 | 21,049 | - | - | Option to purchase shares of common stock | |
| Leah Cann | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2014 | 8,000 | 26,924 | - | - | Option to purchase shares of common stock | |
| Thomas Zech | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2014 | 30,000 | 151,000 | - | - | Option to purchase shares of common stock | |
| Robert Mass | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2014 | 32,000 | 202,659 | - | - | Option to purchase shares of common stock | |
| Charles V. Baltic | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2014 | 8,000 | 26,924 | - | - | Option to purchase shares of common stock | |
| Nicholas Glover | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2014 | 8,000 | 18,793 | - | - | Option to purchase shares of common stock | |
| David M. Urso | Sr. V.P. and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2014 | 30,000 | 150,000 | - | - | Option to purchase shares of common stock | |
| Charles V. Baltic | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Jun 2014 | 1,050 | 17,750 | - | - | Common Stock, par value $0.00000002 | |
| Charles V. Baltic | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Jun 2014 | 950 | 3,850 | - | - | Common Stock, par value $0.00000002 | |
| David M. Urso | Sr. V.P. and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2014 | 120,000 | 120,000 | - | - | Options to purchase shares of common stock | |
| Christine A. White | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2013 | 6,730 | 18,924 | - | - | Option to purchase shares of common stock | |
| William D. Rueckert | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2013 | 6,730 | 18,924 | - | - | Option to purchase shares of common stock | |
| Thomas C. Reynolds | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2013 | 6,730 | 13,049 | - | - | Options to purchase shares of common stock | |
| Leah Cann | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2013 | 6,730 | 18,924 | - | - | Option to purchase shares of common stock | |
| Thomas Zech | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2013 | 10,000 | 121,000 | - | - | Option to purchase shares of common stock | |
| Robert Mass | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2013 | 34,000 | 170,659 | - | - | Option to purchase shares of common stock | |
| Charles V. Baltic | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2013 | 6,730 | 18,924 | - | - | Option to purchase shares of common stock | |
| Nicholas Glover | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2013 | 6,730 | 10,793 | - | - | Options to purchase shares of common stock | |
| Nicholas Glover | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2013 | 4,063 | 4,063 | - | - | Options to purchase shares of common stock | |
| Philippe O. Chambon | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 06 May 2013 | 100,000 | 2,145,475 | - | - | Common Stock | |
| Philippe O. Chambon | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 06 May 2013 | 100,000 | 2,045,475 | - | - | Common Stock | |
| Philippe O. Chambon | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Apr 2013 | 100,000 | 2,402,775 | - | - | Common Stock | |
| Philippe O. Chambon | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Apr 2013 | 157,300 | 2,245,475 | - | - | Common Stock | |
| Daniel P. Gold | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2013 | 400,000 | 400,000 | - | - | Restricted stock units | |
| Christine A. White | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2013 | 4,032 | 12,194 | - | - | Option to purchase shares of common stock | |
| William D. Rueckert | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2013 | 4,032 | 12,194 | - | - | Option to purchase shares of common stock | |
| Leah Cann | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2013 | 4,032 | 12,194 | - | - | Option to purchase shares of common stock | |
| Thomas Zech | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2013 | 81,835 | 111,000 | - | - | Option to purchase shares of common stock | |
| Robert Mass | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2013 | 68,330 | 136,659 | - | - | Option to purchase shares of common stock | |
| Charles V. Baltic | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2013 | 4,032 | 12,194 | - | - | Option to purchase shares of common stock | |
| Philippe O. Chambon | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Feb 2013 | 300,000 | 2,502,775 | - | - | Common Stock | |
| Philippe O. Chambon | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Feb 2013 | 197,225 | 2,802,775 | - | - | Common Stock | |
| Thomas C. Reynolds | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2013 | 6,319 | 6,319 | - | - | Options to purchase shares of common stock | |
| Charles V. Baltic | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Jan 2013 | 4,200 | 11,000 | - | - | Common Stock, par value $0.00000002 per share | |
| Charles V. Baltic | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Jan 2013 | 5,920 | 17,000 | - | - | Common Stock, par value $0.00000002 per share | |
| Charles V. Baltic | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Jan 2013 | 80 | 11,080 | - | - | Common Stock, par value $0.00000002 per share | |
| Charles V. Baltic | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Jan 2013 | 800 | 6,800 | - | - | Common Stock, par value $0.00000002 per share | |
| Charles V. Baltic | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 21 Dec 2012 | 1,700 | 1,700 | - | - | Common Stock, par value $0.00000002 per share | |
| Charles V. Baltic | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 21 Dec 2012 | 1,800 | 4,300 | - | - | Common Stock, par value $0.00000002 per share | |
| Josiah T. Austin | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 06 Dec 2012 | 1,000,000 | 1,000,000 | - | - | Warrants to purchase shares of common stock | |
| William D. Rueckert | None | Other type of transaction at price $ 0.00 per share. | 06 Dec 2012 | 2,988,672 | 2,991,506 | - | - | Warrants to purchase shares of common stock | |
| Josiah T. Austin | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Dec 2012 | 3,478,245 | 3,832,081 | - | - | Common stock, par value $0.00000002 per share | |
| Daniel P. Gold | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2012 | 300,000 | 720,390 | - | - | Options to purchase shares of common stock | |
| Christine A. White | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2012 | 23,810 | 48,979 | - | - | Options to purchase shares of common stock | |
| Bryan Williams | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2012 | 23,810 | 48,979 | - | - | Options to purchase shares of common stock | |
| William D. Rueckert | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2012 | 23,810 | 48,979 | - | - | Options to purchase shares of common stock | |
| Leah Cann | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2012 | 23,810 | 48,979 | - | - | Options to purchase shares of common stock | |
| Charles V. Baltic | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2012 | 23,810 | 48,979 | - | - | Options to purchase shares of common stock | |
| Daniel P. Gold | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2012 | 100,000 | 420,390 | - | - | Options to purchase shares of common stock | |
| Thomas Zech | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2012 | 75,000 | 175,000 | - | - | Options to purchase shares of common stock | |
| Robert Mass | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2012 | 232,359 | 409,979 | - | - | Options to purchase shares of common stock | |
| Charles V. Baltic | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 05 Jul 2012 | 15,000 | 15,000 | - | - | Common stock, par value $0.00000002 per share | |
| Bryan Williams | None | 11 May 2012 | 500 | 0 | - | - | Subscription rights (right to buy) | ||
| Bryan Williams | None | 11 May 2012 | 125 | 125 | - | - | Warrants to purchase shares of common stock | ||
| Bryan Williams | None | 11 May 2012 | 250 | 750 | - | - | Common stock, par value $0.00000002 per share | ||
| William D. Rueckert | None | 11 May 2012 | 2,834 | 0 | - | - | Subscription rights (right to buy) | ||
| William D. Rueckert | None | 11 May 2012 | 2,834 | 2,834 | - | - | Warrants to purchase common stock, par value $0.00000002 | ||
| William D. Rueckert | None | 11 May 2012 | 236 | 654 | - | - | Common stock, par value $0.00000002 per share | ||
| Christine A. White | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2011 | 25,169 | 25,169 | - | - | Options to purchase shares of common stock | |
| Bryan Williams | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2011 | 25,169 | 25,169 | - | - | Options to purchase shares of common stock | |
| William D. Rueckert | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2011 | 25,169 | 25,169 | - | - | Options to purchase shares of common stock | |
| Leah Cann | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2011 | 25,169 | 25,169 | - | - | Options to purchase shares of common stock | |
| Charles V. Baltic | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2011 | 25,169 | 25,169 | - | - | Options to purchase shares of common stock | |
| Daniel P. Gold | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2011 | 100,000 | 320,390 | - | - | Options to purchase shares of common stock | |
| Thomas Zech | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2011 | 26,537 | 100,000 | - | - | Options to purchase shares of common stock | |
| Robert Mass | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2011 | 177,620 | 177,620 | - | - | Options to purchase shares of common stock | |
| Daniel P. Gold | Director, President and Chief Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2010 | 110,195 | 220,390 | - | - | Options to purchase shares of common stock | |
| Philip Johnston | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 May 2009 | 10,000 | 10,000 | - | - | Common Stock, par value $0.00000002 per share | |
| William D. Rueckert | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Nov 2008 | 849 | 20,849 | - | - | Common Stock, par value $0.00000002 per share | |
| William D. Rueckert | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Nov 2008 | 10,000 | 20,000 | - | - | Common Stock, par value $0.00000002 per share | |
| David Ross Seaton | CFO & Secretary | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Mar 2008 | 5,000 | 5,000 | - | - | Common Stock, par value $0.00000002 per share | |
| Bryan Williams | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Mar 2008 | 5,000 | 5,000 | - | - | Common Stock, par value $0.00000002 per share | |
| Christopher Naughton | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Feb 2008 | 1,400 | 1,400 | - | - | Common Stock, par value$0.00000002 per share | |
| Christopher Naughton | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Feb 2008 | 3,600 | 5,000 | - | - | Common Stock | |
| William D. Rueckert | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 21 Dec 2007 | 11 | 989 | - | - | Common Stock, par value $0.00000002 per share | |
| William D. Rueckert | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 21 Dec 2007 | 989 | 0 | - | - | Common Stock | |
| William D. Rueckert | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 21 Dec 2007 | 229 | 229 | - | - | Common Stock | |
| William D. Rueckert | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 21 Dec 2007 | 9,771 | 1,000 | - | - | Common Stock |